biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > have dots been connected yet, jd??

<< Previous

Bullboard Posts

Next >>

Comment by InitiumMMXXIIIon Jan 03, 2025 4:42pm

28 Views

Post# 36386783

RE:RE:RE:RE:RE:have dots been connected yet, jd??

Too obvious, TT, not much thought given there. It conflicts with the entire history of Bioasis and xB3.

Could be true but, unlike with xB3, there is public information that may suggest a different scenario.

You may want to dig deeper, TheTruth1234, so that you might actually stumble upon The Truth.

jd

<< Previous

Bullboard Posts

Next >>

Gold Flora's Gramlin holds court in California cannabis market